关注
João Incio
João Incio
Harvard Medical School
在 steele.mgh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Angiogenesis and chronic inflammation: cause or consequence?
C Costa, J Incio, R Soares
Angiogenesis 10, 149-166, 2007
5582007
Solid stress and elastic energy as measures of tumour mechanopathology
HT Nia, H Liu, G Seano, M Datta, D Jones, N Rahbari, J Incio, ...
Nature biomedical engineering 1 (1), 0004, 2016
3832016
Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy
J Incio, H Liu, P Suboj, SM Chin, IX Chen, M Pinter, MR Ng, HT Nia, ...
Cancer discovery 6 (8), 852-869, 2016
3832016
BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors
AC Faber, RB Corcoran, H Ebi, LV Sequist, BA Waltman, E Chung, J Incio, ...
Cancer discovery 1 (4), 352-365, 2011
3312011
Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
NN Rahbari, D Kedrin, J Incio, H Liu, WW Ho, HT Nia, CM Edrich, K Jung, ...
Science translational medicine 8 (360), 360ra135-360ra135, 2016
2252016
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
J Incio, JA Ligibel, DT McManus, P Suboj, K Jung, K Kawaguchi, M Pinter, ...
Science translational medicine 10 (432), eaag0945, 2018
1892018
Distinguishing the immunostimulatory properties of noncoding RNAs expressed in cancer cells
A Tanne, LR Muniz, A Puzio-Kuter, KI Leonova, AV Gudkov, DT Ting, ...
Proceedings of the National Academy of Sciences 112 (49), 15154-15159, 2015
186*2015
Combined targeting of HER2 and VEGFR2 for effective treatment of HER2-amplified breast cancer brain metastases
DP Kodack, E Chung, H Yamashita, J Incio, AMMJ Duyverman, Y Song, ...
Proceedings of the National Academy of Sciences 109 (45), E3119-E3127, 2012
1712012
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
K Jung, T Heishi, OF Khan, PS Kowalski, J Incio, NN Rahbari, E Chung, ...
The Journal of clinical investigation 127 (8), 3039-3051, 2017
1552017
Metformin reduces desmoplasia in pancreatic cancer by reprogramming stellate cells and tumor-associated macrophages
J Incio, P Suboj, SM Chin, T Vardam-Kaur, H Liu, T Hato, S Babykutty, ...
PloS one 10 (12), e0141392, 2015
1452015
PlGF/VEGFR-1 signaling promotes macrophage polarization and accelerated tumor progression in obesity
J Incio, J Tam, NN Rahbari, P Suboj, DT McManus, SM Chin, TD Vardam, ...
Clinical Cancer Research 22 (12), 2993-3004, 2016
1412016
Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancer
K Jung, T Heishi, J Incio, Y Huang, EY Beech, M Pinter, WW Ho, ...
Proceedings of the National Academy of Sciences 114 (39), 10455-10460, 2017
1152017
Use of angiotensin system inhibitors is associated with immune activation and longer survival in nonmetastatic pancreatic ductal adenocarcinoma
H Liu, K Naxerova, M Pinter, J Incio, H Lee, K Shigeta, WW Ho, JA Crain, ...
Clinical Cancer Research 23 (19), 5959-5969, 2017
882017
Obesity and cancer: an angiogenic and inflammatory link
D Fukumura, J Incio, RC Shankaraiah, RK Jain
Microcirculation 23 (3), 191-206, 2016
712016
Evidence for the effects of xanthohumol in disrupting angiogenic, but not stable vessels
R Negrão, J Incio, R Lopes, I Azevedo, R Soares
International journal of biomedical science: IJBS 3 (4), 279, 2007
232007
Tumor angiogenesis regulators
RR Gonzalez-Perez, BR Rueda
CRC Press, 2013
192013
A phase II study of preoperative (preop) bevacizumab (bev) followed by dose-dense (dd) doxorubicin (A)/cyclophosphamide (C)/paclitaxel (T) in combination with bev in HER2 …
SM Tolaney, DG Duda, Y Boucher, S Goel, J Martin, M Ancukiewicz, ...
Journal of Clinical Oncology 30 (15_suppl), 1026-1026, 2012
132012
BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors. Cancer Discov. 2011; 1: 352–65. doi: 10.1158/2159-8290
AC Faber, RB Corcoran, H Ebi, LV Sequist, BA Waltman, E Chung, J Incio, ...
CD-11-0106.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
7
Tumor Angiogenesis Regulators
J Incio, R Soares, R Ruben, BRR Gonzalez-Perez
P411, 2013
42013
BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors. Cancer Discov 1 (4): 352–365. doi: 10.1158/2159-8290
AC Faber, RB Corcoran, H Ebi, LV Sequist, BA Waltman, E Chung, J Incio, ...
CD-11-0106, 2011
42011
系统目前无法执行此操作,请稍后再试。
文章 1–20